This announcement is a separate document:
山東新華製藥股份：海外監管公告-關於OAB-14幹混懸劑臨床試驗的進展公告
SHANDONG XINHUA: Overseas Regulatory Announcement-Announcement on the Progress of Clinical Trial of OAB-14 Dry Suspension
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.